ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

European Patent Office to Grant MilliporeSigma’s Patent Application for CRISPR Technology – PR Newswire (press release)

Continue reading

2017-08-03 Michael Zand NEWS

CRISPR Helped ‘Edit’ A Human Embryo — But That’s Not All It Can Do – HuffPost


PR Newswire (press release)

European Patent Office to Grant MilliporeSigma’s Patent Application for CRISPR Technology
PR Newswire (press release)
Merck’s patent application covers integration of an external DNA sequence into the chromosome of eukaryotic cells using CRISPR. The patent will give Merck’s CRISPR genomic integration technology broad protection, further strengthening the company’s …

Continue reading

2017-08-03 Michael Zand NEWS

BioTaiwan 2017 concludes, another successful gathering of the region’s life science community – Markets Insider


HuffPost

CRISPR Helped ‘Edit’ A Human Embryo — But That’s Not All It Can Do
HuffPost
Researchers at Oregon Health & Science University, lead by Shoukhrat Mitalipov, used a tool called the Clustered Regularly Interspaced Short Palindromic Repeats, or CRISPR ― a DNA cutting and splicing machine that scientists can “program” to target a …
US scientists have corrected a genetic heart mutation in embryos using CRISPRTechCrunch
Better babies through CrisprBulletin of the Atomic Scientists
Scientists successfully used CRISPR to fix a mutation that causes disease. This is huge.Vox
WIRED –Chemical & Engineering News –The Scientist –MIT Technology Review
all 446 news articles »
Continue reading

2017-08-03 Michael Zand NEWS

Editing Human Embryos With CRISPR Is Moving Ahead—Now’s the Time to Consider Ethics – Observer


Markets Insider

BioTaiwan 2017 concludes, another successful gathering of the region’s life science community
Markets Insider
BioBusiness Asia this year featured a wide range of session themes with a particular emphasis on emerging technologies including precision medicine, next generation sequencing, artificial intelligence (AI), synthetic biology, cancer immunotherapy, and …

and more »

Continue reading

2017-08-02 Michael Zand NEWS

Unmet Needs: Sequencing After Immunotherapy in NSCLC – OncLive

OncLiveUnmet Needs: Sequencing After Immunotherapy in NSCLCOncLiveTranscript: Vassiliki A. Papadimitrakopoulou, MD: One of the most important questions for patients refractory to immunotherapy is, how are we going to sequence therapies beyond chemother… Continue reading

2017-08-02 Michael Zand NEWS

Scientists successfully used CRISPR to fix a mutation that causes disease. This is huge. – Vox


Observer

Editing Human Embryos With CRISPR Is Moving Ahead—Now’s the Time to Consider Ethics
Observer
Editing Human Embryos With CRISPR Is Moving Ahead—Now’s the Time to Consider Ethics. By Jessica Berg • 08/02/17 5:05pm. There’s still a way to go from editing single-cell embryos to a full-term ‘designer baby.’ ZEISS Microscopy. The announcement by …

and more »

Continue reading

2017-08-02 Michael Zand NEWS

#CRISPR DNA Editing Corrects Disease Gene in Human Embryos – Experts Available @UofUHealth – Newswise (press release)


Vox

Scientists successfully used CRISPR to fix a mutation that causes disease. This is huge.
Vox
CRISPR/Cas9 is a gene editing technology that’s revolutionizing science at a breathtaking pace. One of its most exciting, taboo, and controversial applications is tweaking the genes of eggs, sperm, or early embryos to alter a human life. This could one …
US scientists have corrected a genetic heart mutation in embryos using CRISPRTechCrunch
CRISPR Helped ‘Edit’ A Human Embryo — But That’s Not All It Can DoHuffPost
US Scientists Edit a Human Embryo—But Superbabies Won’t Come EasyWIRED
The Conversation AU –CNN –Chemical & Engineering News –MIT Technology Review
all 152 news articles »
Continue reading

2017-08-02 Michael Zand NEWS

ONC201 may inhibit cancer stem cell self-renewals by altering their gene expression – EurekAlert (press release)

ONC201 may inhibit cancer stem cell self-renewals by altering their gene expressionEurekAlert (press release)ONC201 may inhibit cancer stem cell self-renewals by altering their gene expression, according to a study published August 2, 2017 in the open-… Continue reading

2017-08-02 Michael Zand NEWS
  • 1
  • …
  • 1,409
  • 1,410
  • 1,411
  • 1,412
  • 1,413
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

#CRISPR DNA Editing Corrects Disease Gene in Human Embryos – Experts Available @UofUHealth
Newswise (press release)
A study published in Nature reports the first experiment in the U.S. that corrects a disease gene in human embryos using a rapidly rising and powerful DNA editing technology, CRISPR. The advance represents a bold new direction for combatting disease at …